Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Merck KGaA reports two new series of ET antagonists

Nov. 3, 1997

Recordati's lercanidipine launched in The Netherlands

Oct. 31, 1997

Mibefradil and amlodipine compared in patients with exercise-induced and silent ischemia

Oct. 30, 1997

Effects of NO donor ITF-1129 on blood flow/hemodynamics during myocardial ischemia

Oct. 29, 1997

Endothelin antagonists described by Bristol-Myers Squibb

Oct. 29, 1997

Alexion reports phase I/II and IIa results for C5 inhibitor

Oct. 28, 1997

Flamel Technologies reports clinical results on Asacard

Oct. 27, 1997

SmithKline Beecham to copromote Teveten with HMR

Oct. 23, 1997

Novel angiotensin II antagonists for hypertension/CHF

Oct. 23, 1997

Abbott describes new endothelin antagonists

Oct. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...